GaPP: A pilot randomised controlled trial of the efficacy and mechanism of action of gabapentin for the management of chronic pelvic pain in women
Phase of Trial: Phase IV
Latest Information Update: 12 Aug 2016
At a glance
- Drugs Gabapentin (Primary)
- Indications Pelvic pain
- Focus Therapeutic Use
- Acronyms GaPP
- 01 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 02 Oct 2013 Accrual to date is 115% according to United Kingdom Clinical Research Network.
- 02 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.